FOU Nevroklinikken

Vi søker en forskningskoordinator/studie-sykepleier til Seksjon for kliniske studier ved FoU: 2411.webcruiter.no/Main2/Recruit/…

The #GeNeup project is nearing completion! We've collected high-quality data from over 2500 patients and bloodwork from almost 1200 at five Norwegian university hospitals. We're now performing genomic analyses to look for underlying mechanisms of #neuropathicpain.

Vil du bidra til framtidens hjerneforskning? Vi søker en rådgiver til Nevrovit for å jobbe med pasientregistre og forskningsbiobank. En unik mulighet til å sikre kvalitet og fremragende forskning! Les mer og søk her:2411.webcruiter.no/Main2/Recruit/… #Hjerneforskning #Jobbmulighet #NevroVit

Hvor sterk smerte du kjenner, avhenger av hva slags kjønn du har. – Kvinner kan ha blitt overmedisinert med medikamenter som kanskje egentlig ikke fungerer på dem, sier forsker Maria Dehli Vigeland. (M+) morgenbladet.no/aktuelt/2023/1…

Nevrovitenskapelig register og forskningsbiobank er et flaggskip for kvalitet og forskning ved @Oslounivsykehus. For å sikre høy kvalitet og god utvikling har vi nå hatt "audit" med ressurspersoner fra Biobank Norge: Liv Paltiel, Jeanette Aarem og Solveig Kvam. @Biobanken

One of the most downloaded papers in Muscle & Nerve last year was our paper "Which combined nerve conduction study scores are best suited for polyneuropathy in diabetic patients?". Really inspiring! pubmed.ncbi.nlm.nih.gov/34687224/ @nevfys @ResearchNeurOUS @FOU_nevroklin

Ungdommer med traumatiske opplevelser bruker mer smertestillende medisiner enn de som ikke har slike opplevelser. bmjopen.bmj.com/content/13/3/e… @FOU_Nevroklin @NKVTS @theHUNTstudy #traumebevisstomsorg #ungdomshelse #hodepine #muskelskjelett

Warm welcome to Hildegunn and Kristine, two Bachelor students from OsloMet contributing to a research project in the project group of Kaja Nordengen @hjerneforskeren. Here under supervision of Chiara Cappelletti and master student Martine Narum @oslomet @ResearchNeurOUS

We are happy to welcome Chiara Cappelletti as special engineer in the Neuroscience Research Unit laboratory. Together with @ToneBerge5 and @lmp020870, she will run out lab and contribute in different projects for the Division of Neuroscience @ResearchNeurOUS

FoU og Norsk senter for hodepineforskning @NorHEADresearch, gjennomfører nå studien #BioCer, en klinisk studie som undersøker ny forebyggende behandling for migrene: Medikamentfri behandling med biofeedback. Drives av NorHEAD, NTNU, St. Olavs hospital og Ahus.

Fokus på pasientsikkerhet med kurs i Hjerte-lunge redning for alle ansatte ved FoU ♥️🧑‍⚕️

We are close to the end of the #MultipleMS project (EU Horizon project) and have many results to discuss. This year we met in Amsterdam for our annual general assembly.  @ResearchNeurOUS @ToneBerge5 #HorizonEU

Fantastic to again join a conference in person! @ToneBerge5 from FoU and several MS researcher from the Dept of Neurology, Oslo University Hospital are present in Amsterdam on #ECTRIMS2022. This year there are 7000 participants in Amsterdam and 2000 joining digitally.

PhD student Chiara Cappelletti is presenting her on transcriptomic analysis of brain tissue in Parkinsons' disease at a genetic conference in Los Angeles arranged by the American Society of Human Genetics #ASHG2022

Newly published research using MRI data on patients with #lowbackpain and #Modicchanges from the #AIMstudy

Researchers from our department contributed to a the largest genetic study of stroke to date, publ in Nature 30 Sept. The study identifies potential novel drug targets, and for the first time maps genetic risk for stroke across non-European populations. nature.com/articles/s4158…

Newly published research from our postdoc Lars Christian Bråten on "minimal important change" in pain among low back pain patients:

Vi lærer av de beste! Dag O. Hessen @daghes og Anne Spurkland @anspurk glimrende om forskningsformidling på oppstartsseminar med #REMEDY, Forskningssenter for behandling innen revmatologi og muskelskjelettsykdommer.

The final patient included in the researcher-initiated NOR-MS study (Norwegian study of Oral cladribine and Rituximab in MS). 264 patients will be followed for 2 yrs. @OwrenGro @hjernelegen @HanneFH1 @ToneBerge5 @CeliusElisabeth @ResearchNeurOUS @Dr_Overas dagensmedisin.no/artikler/2022/…

As part of the Norwegian Headache Research Centre (NorHEAD), our department will contribute to new and improved treatment for headache disorders. NorHEAD is a Centre for Clinical Treatment Research, funded by the Research Council of Norway @NorHEADresearch @forskningsradet